There are currently 62 active clinical trials seeking participants for Atopic Dermatitis research studies. The states with the highest number of trials for Autism participants are California, Florida, Texas and Ontario.
Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis
NCT05048056
Recruiting
This is a phase 2, multi-center, randomized, placebo-controlled, double-blind, parallel-group, dose-ranging study, conducted in subjects with moderate-to-severe atopic dermatitis.
Gender:
All
Ages:
18 years and above
Trial Updated:
07/04/2022
Locations: AkesoBio Investigative Site 2003, Little Rock, Arkansas +23 locations
Conditions: Atopic Dermatitis
Register for Updates
Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.
NCT05265234
Recruiting
The study is trying to answer the following question: "Can we use non-invasive imaging to evaluate the response of atopic dermatitis (eczema) to Dupixent (dupilumab)?"
Gender:
All
Ages:
18 years and above
Trial Updated:
02/22/2022
Locations: OptiSkin Medical, New York, New York
Conditions: Eczema, Atopic Dermatitis
Register for Updates